Major Market Shift in Vascular Dementia Industry: Rising Prevalence Of Cardiovascular Diseases Boosts The Market

What Is the Forecasted Market Size and Growth Rate for the Vascular Dementia Market?
The market size for vascular dementia has seen a significant surge in the past few years. It is set to expand from a value of $2.92 billion in 2024 to $3.27 billion in 2025, indicating a compound annual growth rate (CAGR) of 12.1%. Factors such as the growing healthcare expenditure, an upswing in the diagnosed cases of vascular dementia, increased number of healthcare practitioners, the proliferation of public health drive, and a heightened prevalence of diabetes contribute to the growth during the historic period.

Expectations are high for the swift expansion of the vascular dementia market in the years to come. The market is predicted to balloon to $5.11 billion by 2029, boasting an 11.8% compound annual growth rate (CAGR). Factors contributing to this anticipated surge during the forecast period include an increased understanding of vascular dementia, a surge in healthcare investment, an ageing population, and the growing incidence of cardiovascular diseases and high blood pressure. Key trends projected during this forecast timeframe consist of technological innovations, customized care plans, telemedicine, gene therapy, and the incorporation of artificial intelligence.

What Factors Are Propelling the Expansion of the Vascular Dementia Market?
The vascular dementia market is predicted to be accelerated by the increasing incidence of cardiovascular disease. These diseases, including cardiovascular disorders such as coronary artery disease, heart failure, arrhythmias, and hypertension, typically affect the heart and blood vessels. Factors such as unhealthy living practices, improper diet, lack of physical activity, heightened stress levels, aging populations, and escalating risk factors like obesity, diabetes, and hypertension are driving this upswing in cardiovascular ailments. Such diseases elevate the likelihood of vascular dementia by disrupting the blood flow to the brain which consequently results in cognitive deterioration and damage to brain cells due to a lack of oxygen and nutrients. Data from the British Heart Foundation, a UK based cardiovascular research charity, in September 2024, suggested around 7.6 million individuals in the UK are distressed by heart and circulatory diseases, which disproportionately includes about 4 million men and 3.6 million women. These disorders account for approximately 27% of total deaths in the UK, tallying over 170,000 deaths per year, or approximately 480 deaths each day. This breaks down to one death every three minutes. Hence, the increasing occurrence of cardiovascular diseases fuels the growth of the vascular dementia market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20998&type=smp

Which Businesses Are at the Forefront of Vascular Dementia Market Development?
Major companies operating in the vascular dementia market are Intermountain Healthcare Inc., CSPC Ouyi Pharmaceutical Co. Ltd., Duke Health, Massachusetts General Hospital, Emory Healthcare Inc., Apollo Hospitals Enterprise Limited, Amedisys Inc., Northwestern Memorial HealthCare, IBS Hospitals Pvt. Ltd., Resverlogix Corp., ProNeurogen Inc., Cyclerion Therapeutics Inc., Aribio Inc., Pinteon Therapeutics Inc., Dementech Neurosciences Ltd., Moleac Pte. Ltd., Isaac Health Inc., Cadabam's Group of Hospitals, Alpha Cognition Inc., Citi Health

What Are the Emerging Trends in the Vascular Dementia Industry?
Major players in the vascular dementia market are concentrating their efforts on the introduction of innovative treatments, such as multimodal therapies, in order to maintain their market standing. A multimodal approach combines various forms of treatment including medication, physical therapy, and psychological methods, for a more all-encompassing disease management. An example is the January 2023 introduction of CognivAiD by Moleac, a biopharmaceutical organization based in Singapore. This was specifically created as an evidence-based remedy for vascular dementia (VaD), a health issue with rather limited treatment options. The product, which incorporates active elements from ginseng, ginkgo and saffron, has demonstrated a notable effect in decelerating cognitive deterioration in VaD sufferers. The combined multimodal effect of CognivAiD targets core mechanisms of vascular dementia comprising vascular conservation, vasoregulation and neuroinflammation. With support from comprehensive clinical trials and a robust safety profile, CognivAiD emerges as a new hope for persons afflicted with VaD.

How Is the Vascular Dementia Market Segmented?
The vascular dementia market covered in this report is segmented -

1) By Product: Monoclonal Antibodies, Small Molecules, Peptides
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
3) By End User: Hospitals And Clinics, Rehabilitation Centers, Specialty Clinics

Subsegments:
1) By Monoclonal Antibodies: Anti-Amyloid Monoclonal Antibodies, Anti-Tau Monoclonal Antibodies
2) By Small Molecules: Cholinesterase Inhibitors, Glutamate Modulators, Anti-Inflammatory Small Molecules
3) By Peptides: Amyloid-Beta Targeted Peptides, Neuroprotective Peptides, Tau-Targeting Peptides

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/vascular-dementia-global-market-report

Where Is the Vascular Dementia Market Growth Most Prominent?
North America was the largest region in the vascular dementia market in 2024. The regions covered in the vascular dementia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Vascular Dementia Global Market Report?

- Market Size Analysis: Analyze the vascular dementia Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the vascular dementia Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the market.
- Market Contribution: Evaluate contributions of different segments to the overall vascular dementia market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the vascular dementia market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20998

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.